Loading clinical trials...
Loading clinical trials...
This study evaluates the prevalence of cannabis withdrawal and the clinical manifestations of cannabis withdrawal syndrome in patients hospitalized for BMT or CAR-T therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
NCT07291011 · Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
NCT06311214 · Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm
NCT05687110 · Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
NCT04771520 · Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8, and more
NCT06501040 · Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Mayo Clinic in Arizona
Scottsdale, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions